Awardee OrganizationBOSTON UNIVERSITY MEDICAL CAMPUS
Description
Abstract Text
DESCRIPTION (provided by applicant): Boston University Clinical HIV/AIDS Research Training (BU-CHART) Program will provide postgraduate training to physicians that will enhance their ability to design and carry out ethical human HIV/AIDS research among disadvantaged populations. The BU-CHART Program, a collaborative effort between the Boston University Medical Center (BUMC) Schools of Public Health and Medicine, will provide training in clinical trials and epidemiologic research in HIV/AIDS with particular focus on the ethical issues of research in disadvantaged populations. Boston University Medical Center serves a population of HIV-infected persons that is largely minority and has high rates of substance abuse; BUMC has an internationally recognized health law department that has been in the forefront of analysis of ethical issues in HIV/AIDS research and a nationally recognized group of substance abuse researchers. BUMC has both adult and pediatric AIDS Clinical Trials Units that are part of the national AIDS Clinical Trials Groups (ACTG) and a substantial number of R01 and other funded studies to provide clinical research opportunities for BU-CHART trainees. The program will enroll two fellows per year in a structured program of mentored clinical research leading to the M.Sc. Degree. Trainees will participate in the didactic clinical research curriculum and a clinical research seminar series, both developed at BUMC through a K30 award. They will also help design, conduct and analyze a clinical research project under the guidance of a mentor chosen from our experienced faculty. A working knowledge of trial design issues, IRB considerations and the preparation of proposals/manuscripts will be provided by the BU-CHART Program. This will prepare trainees for success in future independent clinical research careers.
National Institute of Allergy and Infectious Diseases
CFDA Code
856
DUNS Number
604483045
UEI
FBYMGMHW4X95
Project Start Date
01-August-2003
Project End Date
31-May-2008
Budget Start Date
01-June-2005
Budget End Date
31-May-2006
Project Funding Information for 2005
Total Funding
$353,257
Direct Costs
$331,283
Indirect Costs
$21,974
Year
Funding IC
FY Total Cost by IC
2005
National Institute of Allergy and Infectious Diseases
$353,257
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5T32AI052074-03
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5T32AI052074-03
Patents
No Patents information available for 5T32AI052074-03
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5T32AI052074-03
Clinical Studies
No Clinical Studies information available for 5T32AI052074-03
News and More
Related News Releases
No news release information available for 5T32AI052074-03
History
No Historical information available for 5T32AI052074-03
Similar Projects
No Similar Projects information available for 5T32AI052074-03